Palliative care needs are everywhere
Where do we begin?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The concept of palliative care in neurology continues to evolve; yet, the stigma about palliative care remains. Some may view offering palliative care to patients with serious neurologic conditions as a medical failure. Until recently, most clinicians have associated palliative care with end-of-life care for patients with malignancy. Fortunately, many have increasingly recognized that end-of-life care is an important aspect of care for patients with neurologic conditions. In recent years, the concept of palliative care has expanded further to include care that focuses on physical, psychosocial, intellectual, and spiritual needs, with the goal of improving quality of life for all patients with serious illness. Thus, palliative care may be appropriate during any phase of serious illness.1 Many neurologic disorders (e.g., multiple sclerosis, stroke, amyotrophic lateral sclerosis, and Parkinson disease) fall within this framework. Neuropalliative care has begun to emerge as a specialty to address these important needs of our patients and their families.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 217
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
Alert Me
Recommended articles
-
Views & Reviews
Neuropalliative carePriorities to move the field forwardClaire J. Creutzfeldt, Benzi Kluger, Adam G. Kelly et al.Neurology, June 27, 2018 -
Contemporary Issues
Models of outpatient neuropalliative care for patients with amyotrophic lateral sclerosisJoel N. Phillips, Jessica Besbris, Laura A. Foster et al.Neurology, September 15, 2020 -
Article
Inpatients with neurologic disease referred for palliative care consultationBreana L. Taylor, David L. O'Riordan, Steven Z. Pantilat et al.Neurology, March 27, 2019 -
Resident and Fellow Section
Emerging Subspecialties in Neurology: Neuropalliative careMaisha T. Robinson, Kevin M. Barrett et al.Neurology, May 26, 2014